Analyst Ratings for BioMarin Pharmaceutical Inc. (bmrn)

bmrn Rating Summary

bmrn Price Target Summary

* Over Last 12-Mos
  |   Expand Research on bmrn
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $79.70 (+29.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/24/2014 Goldman Sachs Downgrade Neutral
(Buy)
84.00
(N/A)
73.93 61.37 -16.99% Details
1/10/2014 Barclays Downgrade Equalweight
(Overweight)
73.00
(75.00)
70.18 61.37 -12.55% Details
Like BMRN Ratings? Also take a look at SNY, SAN, ALXN, RHHBY

BMRN Ratings News